<DOC>
	<DOCNO>NCT00922636</DOCNO>
	<brief_summary>The primary purpose child 's participation study determine whether LY2216684 help pediatric patient attention-deficit/hyperactivity disorder ( ADHD ) ; assess safety LY2216684 side effect might associate .</brief_summary>
	<brief_title>A Study Pediatric Patients With Attention Deficit/Hyperactivity Disorder</brief_title>
	<detailed_description />
	<mesh_term>Disease</mesh_term>
	<mesh_term>Attention Deficit Disorder Hyperactivity</mesh_term>
	<mesh_term>Hyperkinesis</mesh_term>
	<mesh_term>Methylphenidate</mesh_term>
	<mesh_term>Phenylethyl Alcohol</mesh_term>
	<criteria>Patients must meet Diagnostic Statistical Manual Mental Disorders Fourth Edition ( DSMIV ) diagnostic criterion ADHD base Kiddie Schedule Affective Disorders Schizophrenia School Aged ChildrenPresent Lifetime ( KSADSPL ) prior randomization . Patients must AttentionDeficit/Hyperactivity Disorder Rating ScaleIVParent Version : InvestigatorAdministered Scored ( ADHDRSIVPV : IR ) total score least 1.5 standard deviation age/gender norm prior randomization . They must Clinical Global ImpressionAttention Deficit Hyperactivity DisorderSeverity Scale ( CGIADHDS ) score great equal 4 patient screen visit , prior randomization . Patients must laboratory result ; show clinically significant abnormality . Patients must normal intelligence , assess investigator . Patients/parents must judge investigator reliable keep appointment clinic visit test , include venous puncture examination require protocol . Patients childbearing potential agree use reliable method birth control study 1 month follow last dose study drug . Female patient childbearing potential must test negative pregnancy time enrollment base urine pregnancy test . Patients weigh less 18 kg great 75 kg screen randomization . Female patient pregnant breastfeeding . Patients history Bipolar I/ II , psychosis , pervasive developmental disorder . Patients current motor tic diagnosis Tourette 's Syndrome . Patients mark anxiety , tension , agitation sufficient , contraindicate treatment extendedrelease methylphenidate . Patients history seizure disorder , know electroencephalographic ( EEG ) abnormalities absence seizure . If electrocardiogram ( ECG ) assess screening/prior randomization show abnormality meet one absolute exclusion criterion list Pediatric ECG Alert Criteria must exclude study . Patients , opinion investigator , serious suicidal risk . Patients history severe allergies one class medication , multiple adverse drug reaction , know hypersensitivity extendedrelease methylphenidate . Patients history alcohol drug abuse within past 3 month prior , currently use alcohol , drug abuse , prescribed overthecounter medication manner investigator considers indicative abuse . Patients screen positive drug abuse prescribed physician participate . Drug screen may repeat discretion investigator , patient may allow enter study repeat screen negative . All patient must negative drug screen enrollment study . Patients medical condition would increase sympathetic nervous system activity markedly , take medication daily basis sympathomimetic activity exclude . Such medication take asneeded basis . Patients problem would exacerbate increased norepinephrine tone , include history cardiovascular disease , thyroid dysfunction , glaucoma , urinary retention , severe gastrointestinal narrowing . Patients , time study , likely need psychotropic medication apart drug study . Patients , time study , likely begin structured psychotherapy aim ADHD symptom exclude . Psychotherapy initiate least 1 month prior screen acceptable . Patients used monoamine oxidase inhibitor ( MAOI ) 2 week prior randomization . Patients current past history clinically significant hypertension . Patients currently enrol , discontinue within last 30 day clinical trial involve offlabel use investigational drug , concurrently enrol type medical research . Patients participate prior study LY2216684 .</criteria>
	<gender>All</gender>
	<minimum_age>6 Years</minimum_age>
	<maximum_age>17 Years</maximum_age>
	<verification_date>July 2014</verification_date>
</DOC>